Literature DB >> 8399396

The role of the carbohydrate chains of Gal beta-1,4-GlcNAc alpha 2,6-sialyltransferase for enzyme activity.

D G Fast1, J C Jamieson, G McCaffrey.   

Abstract

Gal beta-1,4-GlcNAc alpha 2,6-sialyltransferase (CMP-N-acetylneuraminate:beta-galactoside alpha 2,6 sialyltransferase, EC 2.4.99.1) is a glycoprotein containing carbohydrate chains of the complex type (Jamieson, J.C. (1989) Life Sci. 43, 691-697). The carbohydrate chains may be important for controlling the expression of sialyltransferase catalytic activity during transit of the enzyme from the rough endoplasmic reticulum to the Golgi complex where it is active as a membrane bound enzyme anchored to the luminal face. To study the role of the carbohydrate chains of sialyltransferase for enzyme activity, conditions were established in which the native enzyme was deglycosylated with N-Glycanase and endo F. It was found that Glycanase removed the carbohydrate chains from native sialyltransferase, but methanol or ethanol had to be present for rapid and complete deglycosylation. Presence of methanol or ethanol were not essential for removal of carbohydrate chains with endo F. There was a correlation between the loss of catalytic activity of sialyltransferase with increased deglycosylation. After deglycosylation with Glycanase for 18 h catalytic activity was largely eliminated and there was a reduction in molecular mass of about 5 kDa compared to the untreated enzyme when examined by immunoblot analysis; this reduction was identical to that found when the denatured enzyme was deglycosylated with Glycanase. At shorter times of incubation partially deglycosylated forms of the enzyme were detected. Complete deglycosylation of native or denatured sialyltransferase with endo F could not be achieved. However, incubation with endo F for 24 h resulted in a loss of catalytic activity of about 60%. Immunoblot analysis showed the presence of three forms of the enzyme corresponding in molecular mass to the native and deglycosylated enzyme and a third form corresponding to a partially deglycosylated enzyme. Sialyltransferase was also subjected to sequential treatment with exoglycosidases. Removal of NeuAc and Gal had little effect on catalytic activity, but subsequent removal of GlcNAc resulted in a significant loss in catalytic activity suggesting that the presence of the trimannose core with GlcNAc attached is important for the expression of catalytic activity. The presence of organic solvents during deglycosylation with Glycanase may be a useful method that can be applied to other glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8399396     DOI: 10.1016/0167-4838(93)90023-k

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Overexpression of alpha2,3 sialyltransferase in neuroblastoma cells results in an upset in the glycosylation process.

Authors:  N Georgopoulou; K C Breen
Journal:  Glycoconj J       Date:  1999-10       Impact factor: 2.916

2.  Retinoic acid induction of sialyltransferase activity in neuroblastoma cells of differing sialylation potentials.

Authors:  N Georgopoulou; K C Breen
Journal:  Glycoconj J       Date:  2000-11       Impact factor: 2.916

Review 3.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

4.  Construction of a library of human glycosyltransferases immobilized in the cell wall of Saccharomyces cerevisiae.

Authors:  Yoh-Ichi Shimma; Fumie Saito; Fumi Oosawa; Yoshifumi Jigami
Journal:  Appl Environ Microbiol       Date:  2006-08-25       Impact factor: 4.792

5.  Enzymatic basis for N-glycan sialylation: structure of rat α2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation.

Authors:  Lu Meng; Farhad Forouhar; David Thieker; Zhongwei Gao; Annapoorani Ramiah; Heather Moniz; Yong Xiang; Jayaraman Seetharaman; Sahand Milaninia; Min Su; Robert Bridger; Lucas Veillon; Parastoo Azadi; Gregory Kornhaber; Lance Wells; Gaetano T Montelione; Robert J Woods; Liang Tong; Kelley W Moremen
Journal:  J Biol Chem       Date:  2013-10-23       Impact factor: 5.157

Review 6.  The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role.

Authors:  F Dall'Olio
Journal:  Glycoconj J       Date:  2000-10       Impact factor: 2.916

7.  Glycosylation of the N-terminal potential N-glycosylation sites in the human alpha1,3-fucosyltransferase V and -VI (hFucTV and -VI).

Authors:  L L Christensen; P Bross; T F Ørntoft
Journal:  Glycoconj J       Date:  2000-12       Impact factor: 2.916

8.  A novel carbohydrate-deficient glycoprotein syndrome characterized by a deficiency in glucosylation of the dolichol-linked oligosaccharide.

Authors:  P Burda; L Borsig; J de Rijk-van Andel; R Wevers; J Jaeken; H Carchon; E G Berger; M Aebi
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  N-glycosylation is required for full enzymic activity of the murine galactosylceramide sulphotransferase.

Authors:  Matthias Eckhardt; Simon N Fewou; Ivonne Ackermann; Volkmar Gieselmann
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

10.  Studies on the effect of mevinolin (lovastatin) and mevastatin (compactin) on the fusion of L6 myoblasts.

Authors:  R S Belo; J C Jamieson; J A Wright
Journal:  Mol Cell Biochem       Date:  1993-09-22       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.